Latest News & Features
Refine Search
Europe
A UK appellate court has revived a key patent for the tech, finding flaws in the lower court’s handling of the case and obviousness analysis over prior art. 18 December 2025
Europe
The High Court’s ruling clarifies aspects of the SPC waiver but leaves unresolved questions relating to export-country rights and confidentiality, say Claire Phipps-Jones and Luke Norton of Bristows. 18 December 2025
Americas
The proponents of a petition denied by the Supreme Court said it addressed a conflict that was significant “not just for the pharmaceutical industry, but for all stakeholders in our patent system”. 17 December 2025
Careers
The firm’s new hire is known for advising Boston’s biotech, pharmaceutical and chemical companies on patent strategies and commercialising scientific inventions. 17 December 2025
Europe
High-value IP disputes are reshaping life sciences litigation, with perspectives from McDermott Will & Emery, Curevac, Regeneron, HGF, and the UPC. 17 December 2025
Europe
UK court hears claims that a delay and construction inconsistency led to the alleged wrongful invalidation of a patent at the heart of a global dispute. 16 December 2025
Americas
Companies that integrate data rights into their IP strategy with a holistic approach will lead in innovation while minimising risk, says Terri Shieh-Newton of Mintz. 16 December 2025
Careers
The proposed 1,400-strong firm will combine Taylor Wessing's top UK and European practice with Winston & Strawn's US-focused IP litigation team. 15 December 2025
Europe
The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory hurdles, and talent shortages are raising questions about whether the target is achievable, finds Marisa Woutersen. 15 December 2025
Americas
Israeli drug maker bows to FTC pressure, removing scores of “improperly listed” patents in boon for generic manufacturers. 11 December 2025


